Mutations, amplification, and overexpression of well-known oncogenes, such as PI3K subunit-α, FGF1, MYC, EGFR, KRAS, HER2, and AKT2, have been also associated with ovarian cancer [56]. This evidence concerns the gene ERBB2 and ovarian cancer.